demonstrated that heparan sulfate and heparin may inhibit PAR‐1 activation by displacing binding to thrombin and thereby impairing carcinoma cell collagen invasion and degradation and attenuation of invasiveness of MDA‐MB231 cells 29. Here, F2R is linked to carcinoma.